Global Healthcare Analytics Market Forecast 2022-2030

The global healthcare analytics market is forecasted to register a CAGR of 25.24% over the estimated years of 2022 to 2030. The market growth is credited to the increasing demand for big data, the role of technology in reducing healthcare costs, and the surging adoption of HER in developing as well as developed countries.

MARKET INSIGHTS

Healthcare analytics entails healthcare assessment activities undertaken as a result of information collected from various medical areas. These include pharmaceutical and research and development data, patient behavior and sentiment data, and clinical data.

Over recent years, the use of big data has rapidly increased, playing an essential role across numerous sectors, businesses, and governmental organizations. For instance, while manufacturers and transportation firms rely on big data for managing their supply chains and optimizing delivery routes, financial services companies use big data systems for real-time analysis of market data and risk management. Likewise, the use of big data across the healthcare industry facilitates the easier collection of real-time data, in addition to saving time. Besides, it bolsters healthcare marketing, as well.

REGIONAL INSIGHTS

The global healthcare analytics market growth evaluation comprises the assessment of the Asia-Pacific, North America, Europe, and Rest of World. The Asia-Pacific is projected to progress with the highest CAGR over the forecasted years. The growth of the regional market is accredited to the surging amount of complex data, the rise in government initiatives for increasing data analytics in the healthcare sector, and the rapid adoption of EHR.

COMPETITIVE INSIGHTS

The industrial rivalry within the global healthcare analytics market is intense. Furthermore, market leaders are attempting to develop data collection tools, healthcare analytics software, and others with the intent to supply these solutions worldwide.

Leading players operating in the market are IBM Corporation, Oracle, IQVIA, Inovalon, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation cater to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 22288

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. INCREASED DEMAND FOR BIG DATA
- 3.1.2. INCREASING ADOPTION OF EHR IN DEVELOPING AND DEVELOPED COUNTRIES
- 3.1.3. TECHNOLOGY REDUCES HEALTHCARE COSTS
3.2. KEY RESTRAINTS
- 3.2.1. INCREASING NUMBER OF DATA BREACHES
- 3.2.2. HIGH IMPLEMENTATION COSTS
- 3.2.3. TECHNOLOGY-CHALLENGED USERS

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON THE HEALTHCARE ANALYTICS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. KEY BUYING CRITERIA
- 4.6.1. QUALITY OF REPORTING
- 4.6.2. SOFTWARE MUST BE PATIENT-FOCUSED
- 4.6.3. DATA COLLECTION AND ANALYTICS TOOL
- 4.6.4. COST-EFFECTIVENESS
4.7. VALUE CHAIN ANALYSIS

5. MARKET BY TYPE

5.1. DESCRIPTIVE ANALYTICS
5.2. PREDICTIVE ANALYTICS
5.3. PRESCRIPTIVE ANALYTICS

6. MARKET BY DELIVERY MODE

6.1. ON-PREMISE
6.2. ON-DEMAND

7. MARKET BY COMPONENT

7.1. SERVICES
7.2. SOFTWARE
7.3. HARDWARE

8. MARKET BY APPLICATION

8.1. FINANCIAL ANALYTICS
8.2. CLINICAL ANALYTICS
8.3. OPERATIONAL AND ADMINISTRATIVE ANALYTICS
8.4. POPULATION HEALTH ANALYTICS

9. MARKET BY END-USER

9.1. PAYER
9.2. PROVIDER
9.3. ACOS, HIES, MCOS, AND TPAS

10. GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
- 10.1.1. MARKET SIZE & ESTIMATES
- 10.1.2. KEY GROWTH ENABLERS
- 10.1.3. KEY CHALLENGES
- 10.1.4. KEY PLAYERS
- 10.1.5. COUNTRY ANALYSIS
  - 10.1.5.1. UNITED STATES
  - 10.1.5.2. CANADA
10.2. EUROPE
- 10.2.1. MARKET SIZE & ESTIMATES
- 10.2.2. KEY GROWTH ENABLERS
- 10.2.3. KEY CHALLENGES
- 10.2.4. KEY PLAYERS
- 10.2.5. COUNTRY ANALYSIS
  - 10.2.5.1. UNITED KINGDOM
  - 10.2.5.2. GERMANY
  - 10.2.5.3. FRANCE
  - 10.2.5.4. ITALY
  - 10.2.5.5. SPAIN
  - 10.2.5.6. NORDIC COUNTRIES
  - 10.2.5.7. RUSSIA
  - 10.2.5.8. REST OF EUROPE
10.3. ASIA-PACIFIC
- 10.3.1. MARKET SIZE & ESTIMATES
- 10.3.2. KEY GROWTH ENABLERS
- 10.3.3. KEY CHALLENGES
- 10.3.4. KEY PLAYERS
- 10.3.5. COUNTRY ANALYSIS
  - 10.3.5.1. CHINA
  - 10.3.5.2. JAPAN
  - 10.3.5.3. INDIA
  - 10.3.5.4. SOUTH KOREA
  - 10.3.5.5. INDONESIA
  - 10.3.5.6. VIETNAM
  - 10.3.5.7. AUSTRALIA & NEW ZEALAND
  - 10.3.5.8. REST OF ASIA-PACIFIC
10.4. REST OF THE WORLD
- 10.4.1. MARKET SIZE & ESTIMATES
- 10.4.2. KEY GROWTH ENABLERS
- 10.4.3. KEY CHALLENGES
- 10.4.4. KEY PLAYERS
- 10.4.5. REGIONAL ANALYSIS
  - 10.4.5.1. LATIN AMERICA
  - 10.4.5.2. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

11.1. KEY STRATEGIC DEVELOPMENTS
- 11.1.1. MERGERS & ACQUISITIONS
- 11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 11.1.3. PARTNERSHIPS & AGREEMENTS
11.2. COMPANY PROFILES
- 11.2.1. ALLSCRIPTS
- 11.2.2. CERNER
- 11.2.3. CVS HEALTH
- 11.2.4. ELSEVIER
- 11.2.5. HEALTH CATALYST
- 11.2.6. HMS (VITREOSHEALTH)
- 11.2.7. IBM CORPORATION
- 11.2.8. INOVALON
- 11.2.9. IQVIA
- 11.2.10. MCKESSON
- 11.2.11. MEDEANALYTICS
- 11.2.12. OPTUM
- 11.2.13. ORACLE
- 11.2.14. SAS INSTITUTE
- 11.2.15. VERISK ANALYTICS INC